SEC Company Response from PACIFICHEALTH LABORATORIES INC (CIK 0001000278) — Jul 15, 2005
PACIFICHEALTH LABORATORIES INC (CIK 0001000278)
Date: July 15, 2005 · CIK: 0001000278 · Accession: 0000950116-05-002456
AI Filing Summary & Sentiment
Referenced dates: July 1, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
<PAGE>
July 14, 2005
Jim B. Rosenberg
Senior Assistant Chief Accountant
Division of Corporate Finance
Securities and Exchange Commission
Washington, D.C. 20549
Re: PacificHealth Laboratories, Inc.
Form 10-QSB for Quarterly Period Ended March 31, 2005
File No. 0-23495
-----------------------------------------------------
Dear Mr. Rosenberg:
This is in response to your letter dated July 1, 2005, addressed to the
undersigned containing the staff's questions regarding the above referenced Form
10-QSB.
Financial Statements
--------------------
2. Revenue Recognition, pages 6-7.
----------------------------------
This customer has been our largest customer for our endurance products since
1999. Prior to 2004, no sales minimums were required on any sales to this
customer. In 2004, we entered the strength-training market by signing an
exclusive purchasing agreement with the aforementioned customer. Starting in
2004, both the endurance products and the strength products were sold pursuant
to formal, written purchase agreements with predetermined minimum sales
thresholds with this customer.
In 2004, the Company analyzed the historical sales experience for its endurance
products and its projected sales volumes for its strength-training products and
concluded that all products sold to this customer would achieve the minimum
sales thresholds defined in the purchase agreements. In March of 2005, it became
clear that 3 out of 5 the Company's strength-training products would not achieve
the sales minimums defined in the December 2003 purchase agreement which
governed the strength products to be sold in 2004 and for the first time
contained minimums. As a result, all products that did not meet the sales
minimums and were not sold through to the customer's end user were subject to
return provisions defined in the purchase agreement. Also in March 2005, this
customer notified the Company that it was discontinuing the entire suite of
strength-training products. This included strength-training products that had
met the minimum sell-through requirements as defined in the December 2003
purchase agreement. Since this customer was the largest customer for the
Company's endurance products, the Company made a business decision to accept
returns for the strength-training products that had met the minimum sell-through
requirements defined in the December 2003 purchase agreement even though the
Company was not legally obligated to do so.
<PAGE>
In April 2005, a new purchase agreement was signed with this customer that
increased the minimum levels of retail sell-through for all endurance products
sold to this customer. Based on analysis of historical sales volumes, the
Company determined that 9 endurance products could not demonstrate that they
could meet the sales minimums defined in the new agreement. Based on the
historical analysis described above, the Company determined that 3 endurance
products could demonstrate that they could meet the sales minimums defined in
the new agreement, but that the margin for error would be approximately 8%.
Based on the higher minimums established in the April 2005 purchase agreement
and the fact that the Company has agreed to accept returns from the customer
even though it was not legally required to do so, the Company felt it was
appropriate to recognize revenue when products are sold through to the consumer
by this customer effective January 1, 2005.
The Company believes the aforementioned revenue recognition policy is
appropriate in the context of SFAS 48 as the Company is essentially selling
products to this customer with a right of return and all the conditions of
paragraph 6 of SFAS 48 have not been met, specifically the Company does not feel
it has the ability to estimate future returns on sales made to this customer.
Very truly yours,
Stephen P. Kuchen
CFO/COO
</TEXT>
</DOCUMENT>